Welcome to People on the move, a new concept we’re trialling for Insight’s e-newsletter and website to keep the ophthalmic industry updated on new appointments and personnel changes. Read more
Prednefrin Forte shortage: supplier working towards providing alternative
The Therapeutic Goods Administration (TGA) has confirmed a shortage of Prednefrin Forte 10mL eye drops in Australia, which isn’t expected to be available until January next year, but its supplier has confirmed it is working towards providing an alternative product. Read more
Awareness of diabetic eye diseases lacking – MDFA poll
A survey of Australia’s working-age population has revealed that most can’t name the most common cause of blindness among their age group – diabetic retinopathy (DR). Read more
Hoya releases three-year follow-up study of myopia spectacle lens
New data published in the British Journal of Ophthalmology (BJO) has shown Hoya’s MiyoSmart lens continued to slow myopia progression in children after three years, while patients who switched from single vision lenses had a significant slowdown in their condition. Read more
Novartis secures PBS recommendation for Beovu
An independent expert panel has recommended Novartis’ treatment Beovu be subsidised through the Pharmaceutical Benefits Scheme (PBS) for neovascular age-related macular degeneration (nAMD) patients as a second-line anti-VEGF treatment. Read more
Virtual conference attracts new allies in second year
Optometry Australia (OA) has announced it is hosting the Optometry Virtually Connected (OVC) conference for a second consecutive year, after the inaugural event attracted 2,200 delegates in 2020. Read more
Global IOL market to reach AU$6.2bn by 2030 – report
A global data and analytics company has valued the 2020 intraocular lens (IOL) market at US$3.5 billion (AU$4.5 b), however the current resurgence in cataract procedures won’t offset COVID-19 revenue losses until 2022. Read more
New data shows iTrack efficacy as both standalone and combined MIGS procedure
Nova Eye Medical has published two-year data for its iTrack ab-interno canaloplasty procedure, which it says showed an average reduction in mean intraocular pressure (IOP) of 30%, irrespective of whether it was performed standalone or with cataract surgery. Read more
Haag-Streit myopia device arrives in Australia
Haag-Streit’s new myopia management platform Lenstar Myopia is now available in Australia through distributor Device Technologies. Read more
Most pressing eye health issues raised with PM
The state of public cataract surgery and Indigenous eye health were among the key issues a delegation from the ophthalmic sector raised in a recent meeting with Prime Minister Scott Morrison. Read more